Dr Emily Reeve

Adjunct Senior Research Fellow UniSA Clinical & Health Sciences

City East Campus (P6-38)
tel +61 8 830 22757

email Emily.Reeve@unisa.edu.au

Research Degree Supervisor

About me

Deprescribing
Polypharmacy
Geriatrics
Dementia

I am a Senior Research Fellow and Senior Lecturer of Pharmacy Practice (at UniSA since 2019). I am currently funded by an NHMRC Investigator Grant (EL2: 2021-2025). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. I also previously held an NHMRC-ARC Dementia Research... Read more

UniSA Clinical & Health Sciences

UniSA Clinical & Health Sciences is addressing society’s most critical and emerging health needs through quality teaching, learning and research excellence.

Tweets by @UniversitySA

Research

Research focus

Clinical Sciences
Public Health and Health Services
Pharmacology and Pharmaceutical Sciences
Medical and Health Sciences
Psychology and Cognitive Sciences

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus

Open access indicates that an output is open access.

Highlights

Year	Output
2020	Reeve, E 2020, 'Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice', Journal of Pharmacy Practice and Research, vol. 50, no. 1, pp. 98-107. Open access 57
2019	Reeve, E, Farrell, B, Thompson, W, Herrmann, N, Sketris, I, Magin, PJ, Chenoweth, L, Gorman, M, Quirke, L, Bethune, G & Hilmer, SN 2019, 'Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary', Medical Journal of Australia, vol. 210, no. 4, pp. 174-179. Open access 56 48
2018	Reeve, E, Moriarty, F, Nahas, R, Turner, JP, Kouladjian O'Donnell, L & Hilmer, SN 2018, 'A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms', Expert Opinion on Drug Safety, vol. 17, no. 1, pp. 39-49. Open access 44 45
2016	Reeve, E, Low, L-F & Hilmer, SN 2016, 'Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study', British Journal of General Practice, vol. 66, no. 649, pp. e552-e560. Open access 118 110
2016	Reeve, E, Low, L-F, Shakib, S & Hilmer, SN 2016, 'Development and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers', Drugs and Aging, vol. 33, no. 12, pp. 913-928. 138 136

Chapters

Year	Output
2020	Reeve, E & Hilmer, SN 2020, 'Polypharmacy and frailty', in D Gu & ME Dupre (eds), Encyclopedia of Gerontology and Population Aging, Springer, Switzerland, pp. 1-5.
2019	Reeve, E, Hilmer, SN & Scott, I 2019, 'Pharmacotherapy and deprescribing', in ZUD Babar (ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy, Elsevier, US, ch. 12 , pp. 117-128.

Journal Articles

Year	Output
2024	Ailabouni, NJ, Weir, KR, Brandt, N, Hanjani, LS, Green, A, Thompson, W, Freeman, CR, Mangin, D, Bohill, R, Furst, C & Reeve, E 2024, 'Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool: reflections and recommendations', Basic and Clinical Pharmacology and Toxicology, vol. 134, no. 1, pp. 121-125. Open access 2
2024	Boyd, CM, Shetterly, SM, Powers, JD, Weffald, LA, Green, AR, Sheehan, OC, Reeve, E, Drace, ML, Norton, JD, Maiyani, M, Gleason, KS, Sawyer, JK, Maciejewski, ML, Wolff, JL, Kraus, C & Bayliss, EA 2024, 'Evaluating the safety of an educational deprescribing intervention: lessons from the optimize trial', Drugs and Aging, vol. 41, no. 1, pp. 45-54. 1
2024	Chua, S, Todd, A, Reeve, E, Smith, SM, Fox, J, Elsisi, Z, Hughes, S, Husband, A, Langford, A, Merriman, N, Harris, JR, Devine, B & Gray, SL 2024, 'Deprescribing interventions in older adults: An overview of systematic reviews', PLoS One, vol. 19, no. 6, article no. e0305215, pp. 1-20. Open access 1
2024	Dowd, LA, Hamada, S, Hattori, Y, Veal, FC, Reeve, E & Cross, AJ 2024, 'A mixed-methods study on the pharmacological management of pain in Australian and Japanese nursing homes', Age and Ageing, vol. 53, no. 2, pp. 1-13. Open access 1
2024	Langford, A V, Bero, L, Lin, CWC, Blyth, FM, Doctor, JN, Holliday, S, Jeon, YH, Moullin, JC, Murnion, B, Nielsen, S, Penm, J, Reeve, E, Reid, S, Wale, J, Osman, R, Gnjidic, D & Schneider, CR 2024, 'Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care', Journal of Clinical Epidemiology, vol. 165, article no. 111204, pp. 1-10. Open access
2024	Langford, A V, Schneider, CR, Reeve, E, Doctor, JN & Gnjidic, D 2024, 'Comment on: 'Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing'', Drugs and Aging, vol. 41, no. 1, pp. 77-78. 1
2024	Langford, AV, Warriach, I, McEvoy, AM, Karaim, E, Chand, S, Turner, JP, Thompson, W, Farrell, BJ, Pollock, D, Moriarty, F, Gnjidic, D, Ailabouni, NJ & Reeve, E 2024, 'What do clinical practice guidelines say about deprescribing? A scoping review', BMJ Quality and Safety, online, pp. 1-12. Open access
2024	Lim, A, Abeyaratne, C, Reeve, E, Desforges, K & Malone, D 2024, 'Using Kane's validity framework to compare an integrated and single-skill objective structured clinical examination', American Journal of Pharmaceutical Education, vol. 88, no. 9, article no. 100756, pp. 1-6.
2024	Maher, D, Reeve, E, Hopkins, A, Tan, JM, Tantiongco, M, Ailabouni, N, Woodman, R, Stamp, L, Bursill, D, Proudman, S & Wiese, M 2024, 'Comparative risk of gout flares when initiating or escalating various urate-lowering therapy: a systematic review with network meta-analysis', Arthritis Care and Research, vol. 76, no. 6, pp. 871-881. Open access 24
2024	McDonald, EG, Lundby, C, Thompson, W, Boyd, C, Farrell, B, Gagnon, C, Herbin, J, Khuong, N, Moriarty, F, Pierson, T, Scott, S, Scott, IA, Silvius, J, Spinewine, A, Steinman, MA, Tannenbaum, C, Trimble, J, Turner, JP & Reeve, E 2024, 'Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks', Expert Review of Clinical Pharmacology, vol. 14, no. 5-6, pp. 443-440. Open access
2024	Reeve, E, Gnjidic, D, Langford, A V & Hilmer, SN 2024, 'Deprescribing antihypertensive drugs in frail older adults', Australian Prescriber, vol. 47, no. 3, pp. 85-90. Open access
2023	Bucsa, C, Onea, M, Rusu, A, Farcas, A, Porojan, M, Dumitrascu, D, Iaru, I, Leucuta, D, Mogosan, C, Reeve, E & Moga, D 2023, 'Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults', Research in Social and Administrative Pharmacy, vol. 19, no. 11, pp. 1471-1479. 1
2023	Fujita, K, Hooper, P, Masnoon, N, Lo, S, Gnjidic, D, Etherton-Beer, C, Reeve, E, Magin, P, Bell, JS, Rockwood, K, O'Donnell, LK, Sawan, M, Baysari, M & Hilmer, SN 2023, 'Impact of a comprehensive intervention bundle including the drug burden index on deprescribing anticholinergic and sedative drugs in older acute inpatients: a non-randomised controlled before-and-after pilot study', Drugs and Aging, vol. 40, no. 7, pp. 633-642. Open access 3 3
2023	Langford, A V, Lin, CC, Bero, L, Blyth, FM, Doctor, J, Holliday, S, Jeon, YH, Moullin, J, Murnion, B, Nielsen, S, Osman, R, Penm, J, Reeve, E, Reid, S, Wale, J, Schneider, CR & Gnjidic, D 2023, 'Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations', Medical Journal of Australia, vol. 219, no. 2, pp. 80-89. Open access 16
2023	Norton, JD, Zeng, C, Bayliss, EA, Shetterly, SM, Williams, N, Reeve, E, Wynia, MK, Green, AR, Drace, ML, Gleason, KS, Sheehan, OC & Boyd, CM 2023, 'Ethical aspects of physician decision-making for deprescribing among older adults with dementia', JAMA network open, vol. 6, no. 10, pp. 1-14. Open access 2
2023	Reeve, E, Bayliss, EA, Shetterly, S, Maiyani, M, Gleason, KS, Norton, JD, Sheehan, OC, Green, AR, Maciejewski, ML, Drace, M, Sawyer, J & Boyd, CM 2023, 'Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed', Age and Ageing, vol. 52, no. 1, pp. 1-9. Open access 6 6
2023	Reeve, E, Chenoweth, L, Sawan, M, Nguyen, TA, Kalisch Ellett, L, Gilmartin-Thomas, J, Tan, E, Sluggett, JK, Quirke, LS, Tran, K, Ailabouni, N, Cowan, K, Sinclair, R, de la Perrelle, L, Deimel, J, To, J, Daly, S, Whitehead, C & Hilmer, SN 2023, 'Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questions', Journal of Alzheimer's Disease, vol. 91, no. 3, pp. 933-960. Open access 4 3 11
2023	Reeve, E, Thompson, W, Boyd, C, Lundby, C & Steinman, MA 2023, 'The state of deprescribing research: how did we get here?', Basic and Clinical Pharmacology and Toxicology, vol. 133, no. 6, pp. 657-660. Open access 5 6
2023	Sheehan, OC, Gleason, KS, Bayliss, EA, Green, AR, Drace, ML, Norton, J, Reeve, E, Shetterly, SM, Weffald, LA, Sawyer, JK, Maciejewski, ML, Kraus, C, Maiyani, M, Wolff, J & Boyd, CM 2023, 'Intervention design in cognitively impaired populations-lessons learned from the OPTIMIZE deprescribing pragmatic trial', Journal of the American Geriatrics Society, vol. 71, no. 3, pp. 774-784. Open access 2 3
2023	Spinewine, A, Reeve, E & Thompson, W 2023, 'Revisiting systematic reviews on deprescribing trials to better inform future practice and research', British Journal of Clinical Pharmacology, vol. 89, no. 12, pp. 3758-3764. 3
2023	Tan, JM, Reeve, E, Fraser, L, Proudman, SM & Wiese, MD 2023, 'The barriers and enablers to the use of parenteral methotrexate in rheumatoid arthritis patients: a scoping review', Arthritis Care and Research, vol. 75, no. 11, pp. 2306-2315. Open access 1 3
2023	Thompson, W, Reeve, E, McDonald, EG, Farrell, B, Scott, S, Steinman, MA, Morin, L & Lundby, C 2023, 'Ten deprescribing articles you should know about: a guide for newcomers to the field', Basic and Clinical Pharmacology and Toxicology, vol. 133, no. 6, pp. 661-664. 3 4
2022	Ailabouni, NJ, Reeve, E, Helfrich, CD, Hilmer, SN & Wagenaar, BH 2022, 'Leveraging implementation science to increase the translation of deprescribing evidence into practice', Research in Social and Administrative Pharmacy, vol. 18, no. 3, pp. 2550-2555. 18 18
2022	Ailabouni, NJ, Weir, KR, Reeve, E, Turner, JT, Wilson Norton, J & Gray, SL 2022, 'Barriers and enablers of older adults initiating a deprescribing conversation', Patient Education and Counseling, vol. 105, no. 3, pp. 615-624. 18 19
2022	Bai, I, Isenor, JE, Reeve, E, Whelan, AM, Martin-Misener, R, Burgess, S & Kennie-Kaulbach, N 2022, 'Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs', Research in Social and Administrative Pharmacy, vol. 18, no. 8, pp. 3350-3357. 12 14
2022	Bayliss, EA, Shetterly, SM, Drace, ML, Norton, JD, Maiyani, M, Gleason, KS, Sawyer, JK, Weffald, LA, Green, AR, Reeve, E, Maciejewski, ML, Sheehan, OC, Wolff, JL, Kraus, C & Boyd, CM 2022, 'Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: the OPTIMIZE pragmatic cluster randomized trial', JAMA Internal Medicine, vol. 182, no. 5, pp. 534-542. Open access 37 37
2022	Gnjidic, D, Johansson, M, Meng, DM, Farrell, B, Langford, A & Reeve, E 2022, 'Achieving sustainable healthcare through deprescribing', Cochrane Database of Systematic Reviews, vol. 10, pp. 1-3. 10 9
2022	Kennie-Kaulbach, N, Kehoe, S, Whelan, AM, Reeve, E, Bai, I, Burgess, S, Kits, O & Isenor, JE 2022, 'Use of a knowledge exchange event strategy to identify key priorities for implementing deprescribing in primary healthcare in Nova Scotia, Canada', Evidence and Policy: A Journal of Research, Debate and Practice, vol. 18, no. 3, pp. 619-630. 2 2
2022	Kouladjian O'Donnell, L, Reeve, E & Hilmer, SN 2022, 'Development, validation and evaluation of the goal-directed medication review electronic decision support system (G-MEDSS)©', Research in Social and Administrative Pharmacy, vol. 18, no. 7, pp. 3174-3183. 4
2022	Scott, IA, Reeve, E & Hilmer, SN 2022, 'Establishing the worth of deprescribing inappropriate medications: are we there yet?', Medical Journal of Australia, vol. 217, no. 6, pp. 283-286. Open access 15 13
2022	Shrestha, S, Poudel, A, Reeve, E, Linsky, AM, Steadman, KJ & Nissen, LM 2022, 'Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy', Research in Social and Administrative Pharmacy, vol. 18, no. 9, pp. 3596-3601. 1 1
2022	Thompson, W & Reeve, E 2022, 'Deprescribing: moving beyond barriers and facilitators', Research in Social and Administrative Pharmacy, vol. 18, no. 3, pp. 2547-2549. 19
2022	Turner, JP, Thompson, W, Reeve, E & Bell, JS 2022, 'Deprescribing proton pump inhibitors', Australian Journal of General Practice, vol. 51, no. 11, pp. 845-848. Open access 7 6
2022	Weir, KR, Ailabouni, NJ, Schneider, CR, Hilmer, SN & Reeve, E 2022, 'Considerations for systematic reviews of quantitative surveys: learnings from a systematic review of the patients' attitudes towards deprescribing questionnaire', Research in Social and Administrative Pharmacy, vol. 18, no. 2, pp. 2345-2349. 3 3
2022	Weir, KR, Ailabouni, NJ, Schneider, CR, Hilmer, SN & Reeve, E 2022, 'Consumer attitudes towards deprescribing: a systematic review and meta-analysis', Journal of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 77, no. 5, pp. 1020-1034. Open access 49 54
2022	White, A, Fulda, KG, Blythe, R, Chui, MA, Reeve, E, Young, R, Espinoza, A, Hendrix, N & Xiao, Y 2022, 'Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety', Expert Opinion on Drug Safety, vol. 21, no. 11, pp. 1357-1364. Open access 3
2021	Ailabouni, NJ, Hilmer, SN, Kalisch, L, Braund, R & Reeve, E 2021, 'COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy', Journal of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 76, no. 6, pp. 1068-1073. Open access 16 13 18
2021	Isenor, JE, Bai, I, Cormier, R, Helwig, M, Reeve, E, Whelan, AM, Burgess, S, Martin-Misener, R & Kennie-Kaulbach, N 2021, 'Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: a scoping review', Research in Social and Administrative Pharmacy, vol. 17, no. 7, pp. 1229-1241. Open access 29 29
2021	Jungo, KT, Mantelli, S, Rozsnyai, Z, Missiou, A, Reeve, E & Streit, S and 35 other authors 2021, 'General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries', BMC Geriatrics, vol. 21, no. 1, article no. 19, pp. 1-12. Open access 22 22
2021	Jungo, KT, Meier, R, Valeri, F, Schwab, N, Schneider, C, Reeve, E, Spruit, M, Schwenkglenks, M, Rodondi, N & Streit, S 2021, 'Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial', BMC Family Practice, vol. 22, article number: 123, pp. 1-14. Open access 14 15
2021	Kouladjian O'Donnell, L, Gnjidic, D, Sawan, M, Reeve, E, Kelly, PJ, Chen, TF, Bell, S & Hilmer, SN 2021, 'Impact of the Goal‐directed Medication review Electronic Decision Support System (G‐MEDSS)© on Drug Burden Index: a cluster‐randomised clinical trial in primary care', British Journal of Clinical Pharmacology, vol. 87, no. 3, pp. 1499-1511. Open access 27 30
2021	Kouladjian O'Donnell, L, Reeve, E, Cumming, A, Scott, IA & Hilmer, SN 2021, 'Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians', Internal Medicine Journal, vol. 51, no. 1, pp. 111-115. Open access 7 8
2021	Kua, C-H, Reeve, E, Tan, DS, Koh, T, Soong, JL, Sim, MJ, Zhang, TY, Chen, YR, Ratnasingam, V, Mak, VS & Lee, SWH 1 consortium 2021, 'Patients' and caregivers' attitudes towards deprescribing in Singapore', Journal of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 76, no. 6, pp. 1053-1060. Open access 17 22
2021	Lo, SY, Reeve, E, Page, AT, Zaidi, STR, Hilmer, SN, Etherton-Beer, C, McLachlan, A, Pont, L & Naganathan, V 2021, 'Attitudes to drug use in residential aged care facilities: a cross-sectional survey of nurses and care staff', Drugs and Aging, vol. 38, no. 8, pp. 697-711. Open access 9 9
2021	Maher, D, Ailabouni, N, Mangoni, AA, Wiese, MD & Reeve, E 2021, 'Alterations in drug disposition in older adults: a focus on geriatric syndromes', Expert Opinion on Drug Metabolism and Toxicology, vol. 17, no. 1, pp. 41-52. Open access 35 31 7
2021	Reeve, E 2021, 'Consideration of frailty versus limited life expectancy when deprescribing: a response to: 'LESS CHRON: a tool for deprescribing in patients with multimorbidity'', Journal of Pharmacy Practice and Research, vol. 51, no. 2, pp. 185-186. Open access
2021	Roux, B, Sirois, C, Niquille, A, Spinewine, A, Ouellet, N, Petein, C, Sibille, FX, Csajka, C & Reeve, E 2021, 'Cross-cultural adaptation and psychometric validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in French', Research in Social and Administrative Pharmacy, vol. 17, no. 8, pp. 1453-1462. 20 21
2021	Sawan, M, Kouladjian O'Donnell, L, Reeve, E, Gnjidic, D, Chen, TF, Kelly, PJ, Bell, S & Hilmer, SN 2021, 'The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation', Research in Social and Administrative Pharmacy, vol. 17, no. 4, pp. 715-722. Open access 12 12
2020	Achterhof, AB, Rozsnyai, Z, Reeve, E, Jungo, KT, Floriani, C, Poortvliet, RK, Rodondi, N, Gussekloo, J & Streit, S 2020, 'Potentially inappropriate medication and attitudes of older adults towards deprescribing', PLoS One, vol. 15, no. 10, article no. e0240463, pp. 1-14. Open access 32 34
2020	Bayliss, E, Shetterly, S, Drace, M, Norton, J, Green, A, Reeve, E, Weffald, L, Wright, L, Maciejewski, M, Sheehan, O, Wolff, J, Gleason, KS, Kraus, C, Maiyani, M, Du Vall, M & Boyd, C 2020, 'The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial', Trials, vol. 21, no. 1, article no. 542, pp. 1-13. Open access 27 23
2020	D'Avanzo, B, Agosti, P, Reeve, E, Pasina, L, Sabbà, C, Mannucci, PM & Nobili, A 2020, 'Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study', Maturitas, vol. 134, pp. 29-33. Open access 11 11
2020	Dearing, ME, Bowles, S, Isenor, J, Kits, O, Kouladjian O'Donnell, L, Neville, H, Hilmer, S, Toombs, K, Sirois, C, Hajizadeh, M, Negus, A, Rockwood, K & Reeve, E 2020, 'Pharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysis', BMJ Open, vol. 10, n0. 2, pp. 1-9. Open access 5 4
2020	Dearing, ME, Bowles, SK, Isenor, JE, Theou, O & Reeve, E 2020, 'Medication-related criteria in frailty assessment tools: a narrative review', Australasian Journal on Ageing, vol. 39, no. 3, pp. e460-e465. Open access
2020	Gnjidic, D & Reeve, E 2020, 'Deprescribing: what do we know, and where to next?', British Journal of Clinical Pharmacology, vol. 87, no. 3, pp. 722-724. Open access 15
2020	Green, A, Boyd, CM, Gleason, KS, Wright, L, Kraus, CR, Bedoy, R, Sanchez, B, Norton, J, Sheehan, OC, Wolff, JL, Reeve, E, Maciejewski, ML, Weffald, LA & Bayliss, EA 2020, 'Designing a primary care-based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study', Journal of General Internal Medicine, vol. 35, no. 12, pp. 3556-3563. Open access 23 23
2020	Kennie-Kaulbach, N, Cormier, R, Kits, O, Reeve, E, Whelan, AM, Martin-Misener, R, Burge, F, Burgess, S & Isenor, JE 2020, 'Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks', Medicine Access at Point of Care, 4, pp. 1-12. Open access
2020	Kouladjian O'Donnell, L, Sawan, M, Reeve, E, Gnjidic, D, Chen, TF, Kelly, PJ, Bell, SJ & Hilmer, SN 2020, 'Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults', BMC Geriatrics, vol. 20, no.1, pp. 1-12. Open access 15 15
2020	Martinez, A I, Spencer, J, Moloney, M, Badour, C, Reeve, E & Moga, DC 2020, 'Attitudes toward deprescribing in a middle-aged health disparities population', Research in Social and Administrative Pharmacy, vol. 16, no. 10, pp. 1502-1507. Open access 10 8
2020	Reeve, E 2020, 'Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice', Journal of Pharmacy Practice and Research, vol. 50, no. 1, pp. 98-107. Open access 57
2020	Sawan, M, Reeve, E, Turner, J, Todd, A, Steinman, MA, Petrovic, M & Gnjidic, D 2020, 'A systems approach to identifying the challenges of implementing deprescribing in older adults across different health care settings and countries: a narrative review', Expert Review of Clinical Pharmacology, vol. 13, no. 3, pp. 233-245. Open access 61 58
2019	Ailabouni, NJ & Reeve, E 2019, 'Can existing tools predict older adults' willingness to deprescribe? Considerations for D-PRESCRIBE's post-hoc secondary analysis', Research in Social and Administrative Pharmacy, vol. 15, no. 11, pp. 1379-1380. 6 6
2019	Farrell, B, Conklin, J, Dolovich, L, Irving, H, Maclure, M, McCarthy, L, Moriarty, F, Pottie, K, Raman-Wilms, L, Reeve, E & Thompson, W 2019, 'Deprescribing guidelines: an international symposium on development, implementation, research and health professional education', Research in Social and Administrative Pharmacy, vol. 15, no. 6, pp. 780-789. Open access 24 23
2019	Gnjidic, D, Ong, HMM, Leung, C, Jansen, J & Reeve, E 2019, 'The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study', Therapeutic Advances in Drug Safety, vol. 10, pp. 1-11. Open access 20 17
2019	Green, AR, Lee, P, Reeve, E, Wolff, JL, Chen, CCG, Kruzan, R & Boyd, CM 2019, 'Clinicians' perspectives on barriers and enablers of optimal prescribing in patients with dementia and coexisting conditions', Journal of the American Board of Family Medicine, vol. 32, pp. 383-391. Open access 27 28
2019	Jungo, KT, Rozsnyai, Z, Mantelli, S, Floriani, C, Reeve, E & Streit, S and 16 other authors 2019, ''Optimising PharmacoTherapy In the multimorbid elderly in primary CAre' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial', BMJ Open, vol. 9, no. 9, article no. e031080, pp. 1-12. Open access 15 14
2019	Kroger, E, Simard, M, Sirois, MJ, Giroux, M, Sirois, C, Kouladjian-O'Donnell, L, Reeve, E, Hilmer, S, Carmichael, PH & Emond, M 2019, 'Is the drug burden index related to declining functional status at follow-up in community-dwelling seniors consulting for minor injuries? Results from the Canadian emergency team initiative cohort study', Drugs and Aging, vol. 36, no. 1, pp. 73-83. 7 6
2019	Laroche, M-L, Sirois, C, Reeve, E, Gnjidic, D & Morin, L 2019, 'Pharmacoepidemiology in older people: purposes and future directions', Therapie, vol. 74, no. 2, pp. 325-332. Open access 9 7
2019	Nguyen, TA, Gilmartin-Thomas, J, Tan, ECK, Kalisch-Ellett, L, Eshetie, T, Gillam, M & Reeve, E 2019, 'The impact of pharmacist interventions on quality use of medicines, quality of life, and health outcomes in people with dementia and/or cognitive impairment: a systematic review', Journal of Alzheimer's Disease, vol. 7, no. 1, pp. 83-96. Open access 20 18 8
2019	Reeve, E, Farrell, B, Thompson, W, Herrmann, N, Sketris, I, Magin, PJ, Chenoweth, L, Gorman, M, Quirke, L, Bethune, G & Hilmer, SN 2019, 'Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary', Medical Journal of Australia, vol. 210, no. 4, pp. 174-179. Open access 56 48
2019	Reeve, E, Low, LF & Hilmer, SN 2019, 'Attitudes of older adults and caregivers in Australia toward deprescribing', Journal of the American Geriatrics Society, vol. 67, no. 6, pp. 1204-1210. 70 70
2019	Thompson, W, Reeve, E, Moriarty, F, Maclure, M, Turner, J, Steinman, MA, Conklin, J, Dolovich, L, McCarthy, L & Farrell, B 2019, 'Deprescribing: future directions for research', Research in Social and Administrative Pharmacy, vol. 15, no. 6, pp. 801-805. Open access 47 46
2018	Mantelli, S, Jungo, KT, Rozsnyai, Z, Reeve, E, Luymes, CH, Poortvliet, RK, Chiolero, A, Rodondi, N, Gussekloo, J & Streit, S 2018, 'How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study', BMC Family Practice, vol. 19, no. 1, article number 169, pp. 1-8. Open access 23 23
2018	Okeowo, D, Patterson, A, Boyd, C, Reeve, E, Gnjidic, D & Todd, A 2018, 'Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?', Therapeutic Advances in Drug Safety, vol. 9, no. 11, pp. 619-630. Open access 18 15
2018	Reeve, E, Anthony, AC, Kouladjian O'Donnell, L, Low, LF, Ogle, SJ, Glendenning, JE, Lorang, CE & Hilmer, SN 2018, 'Development and pilot testing of the revised patients' attitudes towards deprescribing questionnaire for people with cognitive impairment', Australasian Journal on Ageing, vol. 37, no. 4, pp. E150-E154. Open access 34 29
2018	Reeve, E, Moriarty, F, Nahas, R, Turner, JP, Kouladjian O'Donnell, L & Hilmer, SN 2018, 'A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms', Expert Opinion on Drug Safety, vol. 17, no. 1, pp. 39-49. Open access 44 45
2018	Reeve, E, Wolff, JL, Skehan, M, Bayliss, EA, Hilmer, SN & Boyd, CM 2018, 'Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States', JAMA Internal Medicine, vol. 178, no. 12, pp. 1673-1680. Open access 143 134
2017	Babar, Z-U-D, Gammie, TM, Gnjidic, D, Reeve, E, Jordan, V, Hilmer, SN, Hopper, I & Lu, CY 2017, 'Withdrawal of antihypertensive drugs in older people', Cochrane Database of Systematic Reviews, vol. 2017, no. 2, pp. 2-10. Open access 38
2017	Chan, B, Reeve, E, Matthews, S, Carroll, PR, Long, JC, Held, F, Latt, M, Naganathan, V, Caplan, GA & Hilmer, SN 2017, 'Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards', British Journal of Clinical Pharmacology, vol. 83, no. 6, pp. 1185-1196. Open access 16 14
2017	Ong, G-J, Page, A, Caughey, G, Johns, S, Reeve, E & Shakib, S 2017, 'Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy', Pharmacology Research and Perspectives, vol. 5, no. 3, article no. e00321, pp. 1-6. Open access 9 8
2017	Reeve, E & Hilmer, S 2017, 'Tapering or abrupt cessation of proton pump inhibitors?', European Journal of Clinical Pharmacology, vol. 73, no. 7, pp. 923-924. 1 1
2017	Reeve, E, Molin, P, Hui, A & Rockwood, K 2017, 'Exploration of verbal repetition in people with dementia using an online symptom-tracking tool', International Psychogeriatrics, vol. 29, no. 6, pp. 959-966. Open access 13 11
2017	Reeve, E, Ong, M, Wu, A, Jansen, J, Petrovic, M & Gnjidic, D 2017, 'A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people', European Journal of Clinical Pharmacology, vol. 73, no. 8, pp. 927-935. Open access 116 105
2017	Reeve, E, Thompson, W & Farrell, B 2017, 'Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action', European Journal of Internal Medicine, vol. 38, pp. 3-11. Open access 192 182
2017	Reeve, E, Trenaman, SC, Rockwood, K & Hilmer, SN 2017, 'Pharmacokinetic and pharmacodynamic alterations in older people with dementia', Expert Opinion on Drug Metabolism and Toxicology, vol. 13, no. 6, pp. 651-667. Open access 57 51
2017	Sirois, C, Ouellet, N & Reeve, E 2017, 'Community-dwelling older people's attitudes towards deprescribing in Canada', Research in Social and Administrative Pharmacy, vol. 13, no. 4, pp. 864-870. Open access 60 60
2017	Wu, A, Reeve, E, Hilmer, S & Gnjidic, D 2017, 'Hospital pharmacists' beliefs about optimising statin therapy in older inpatients', Journal of Pharmacy Practice and Research, vol. 47, no. 3, pp. 223-227. Open access 5
2016	Galazzi, A, Lusignani, M, Chiarelli, MT, Mannucci, PM, Franchi, C, Tettamanti, M, Reeve, E & Nobili, A 2016, 'Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy', International Journal of Clinical Pharmacy, vol. 38, no. 2, pp. 454-461. 72 67
2016	Gilmartin, JF-M, Nguyen, TA, Reeve, E & Tan, EC 2016, 'Incorporating research into current pharmacy practice: the future of Australian pharmacy?', Journal of Pharmacy Practice and Research, vol. 46, no. 4, pp. 397-398. 1
2016	Kalogianis, MJ, Wimmer, BC, Turner, JP, Tan, EC, Emery, T, Robson, L, Reeve, E, Hilmer, SN & Bell, JS 2016, 'Are residents of aged care facilities willing to have their medications deprescribed?', Research in Social and Administrative Pharmacy, vol. 12, no. 5, pp. 784-788. 61 61
2016	Kouladjian, L, Gnjidic, D, Reeve, E, Chen, TF & Hilmer, SN 2016, 'Health care practitioners' perspectives on deprescribing anticholinergic and sedative medications in older adults', Annals of Pharmacotherapy, vol. 50, no. 8, pp. 625-636. 69 67
2016	Reeve, E, Denig, P, Hilmer, SN & ter Meulen, R 2016, 'The ethics of deprescribing in older adults', Journal of Bioethical Inquiry, vol. 13, no. 4, pp. 581-590. 36 30
2016	Reeve, E, Low, L-F & Hilmer, SN 2016, 'Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study', British Journal of General Practice, vol. 66, no. 649, pp. e552-e560. Open access 118 110
2016	Reeve, E, Low, L-F, Shakib, S & Hilmer, SN 2016, 'Development and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers', Drugs and Aging, vol. 33, no. 12, pp. 913-928. 138 136
2016	Thai, M, Reeve, E, Hilmer, SN, Qi, K, Pearson, S-A & Gnjidic, D 2016, 'Prevalence of statin-drug interactions in older people: a systematic review', European Journal of Clinical Pharmacology, vol. 72, no. 5, pp. 513-521. 25 21
2015	Grzeskowiak, LE, Thomas, AE, To, J, Phillips, AJ & Reeve, E 2015, 'Enhancing education activities for health care trainees and professionals using audience response systems: a systematic review', Journal of Continuing Education in the Health Professions, vol. 35, no. 4, pp. 261-269. 22 20
2015	Grzeskowiak, LE, Thomas, AE, To, J, Reeve, E & Phillips, AJ 2015, 'Enhancing continuing education activities using audience response systems: a single-blind controlled trial', Journal of Continuing Education in the Health Professions, vol. 35, no. 1, pp. 38-45. 14 13
2015	Qi, K, Reeve, E, Hilmer, SN, Pearson, SA, Matthews, S & Gnjidic, D 2015, 'Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia', International Journal of Clinical Pharmacy, vol. 37, no. 5, pp. 949-957. 89 80
2015	Reeve, E & Turner, JP 2015, 'Patients' perspectives on the brave new word 'deprescribing'', International Journal of Pharmacy Practice, vol. 23, no. 1 pp. 90-91. Open access 9
2015	Reeve, E, Andrews, JM, Wiese, MD, Hendrix, I, Roberts, MS & Shakib, S 2015, 'Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors', Annals of Pharmacotherapy, vol. 49, no. 1, pp. 29-38. 71 54 8
2015	Reeve, E, Bell, JS & Hilmer, SN 2015, 'Barriers to optimising prescribing and deprescribing in older adults with dementia: a narrative review', Current Clinical Pharmacology, vol. 10, no. 3, pp. 168-177. 89 57
2015	Reeve, E, Gnjidic, D & Hilmer, S 2015, 'The role of the OncPal deprescribing guideline in end-of-life care', Supportive Care in Cancer, vol. 23, no. 4, pp. 899-899. Open access 3 4
2015	Reeve, E, Gnjidic, D, Long, J & Hilmer, S 2015, 'A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice', British Journal of Clinical Pharmacology, vol. 80, no. 6, pp. 1254-1268. Open access 457 413
2015	Reeve, E, Wiese, MD & Mangoni, AA 2015, 'Alterations in drug disposition in older adults', Expert Opinion on Drug Metabolism and Toxicology, vol. 11, no. 4, pp. 491-508. 83 69 3
2015	Scott, IA, Hilmer, SN, Reeve, E, Potter, K, Le Couteur, D, Rigby, D, Gnjidic, D, Del Mar, CB, Roughead, L, Page, A, Jansen, J & Martin, JH 2015, 'Reducing inappropriate polypharmacy: the process of deprescribing', JAMA Internal Medicine, vol. 175, no. 5, pp. 827-834. Open access 1062 941 543
2015	Thai, M, Hilmer, S, Pearson, SA, Reeve, E & Gnjidic, D 2015, 'Prevalence of potential and clinically relevant statin-drug interactions in frail and robust older inpatients', Drugs and Aging, vol. 32, no. 10, pp. 849-856. 22 21
2014	Reeve, E & Wiese, MD 2014, 'Benefits of deprescribing on patients' adherence to medications', International Journal of Clinical Pharmacy, vol. 36, no. 1, pp. 26-29. 76 65 8
2014	Reeve, E, Shakib, S, Hendrix, I, Roberts, MS & Wiese, MD 2014, 'Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process', British Journal of Clinical Pharmacology, vol. 78, no. 4, pp. 738-747. Open access 255 235 54
2014	Reeve, E, Shakib, S, Hendrix, I, Roberts, MS & Wiese, MD 2014, 'The benefits and harms of deprescribing', Medical Journal of Australia, vol. 201, no. 7, pp. 386-389. Open access 84 60 22
2014	Tan, EC, Visvanathan, R, Hilmer, SN, Vitry, A I, Quirke, T, Emery, T, Robson, L, Shortt, T, Sheldrick, S, Lee, SW, Clothier, R, Reeve, E, Gnjidic, D, Ilomaki, J & Bell, JS 2014, 'Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol', BMJ Open, vol. 4, no. 6, article number e005757, pp. 1-6. Open access 31 33
2013	Reeve, E, Shakib, S, Hendrix, I, Roberts, MS & Wiese, MD 2013, 'Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire', International Journal of Clinical Pharmacy, vol. 35, no. 1, pp. 51-56. 82 78
2013	Reeve, E, To, J, Hendrix, I, Shakib, S, Roberts, MS & Wiese, MD 2013, 'Patient barriers to and enablers of deprescribing: a systematic review', Drugs and Aging, vol. 30, no. 10, pp. 793-807. Open access 365 340
2013	Reeve, E, Wiese, MD, Hendrix, I, Roberts, MS & Shakib, S 2013, 'People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe', Journal of the American Geriatrics Society, vol. 61, no. 9, pp. 1508-1514. 187 165

Reports

Year	Output
2020	Hilmer, S, Gnjidic, D, Reeve, E, Kalisch, L, Wu, H & Raymond, J 2020, Use of antipsychotic medicines: a literature review, Australian Commission on Safety and Quality in Health Care, Australia. Open access
2020	Isenor, J, Kennie-Kaulbach, N, Kehoe, S, Bai, I, Reeve, E, Whelan, AM, Burgess, S, Kits, O, Burge, F, Martin-Misener, R, Helwig, M & Sampalli, T 2020, Key priorities to implement deprescribing in primary health care in Nova Scotia: results from the deprescribing in primary health care in Nova Scotia knowledge exchange event (June 20, 2019), Dalhousie University, Canada. Open access
2018	Hilmer, S, Reeve, E & Thompson, J 2018, Quality use of medicines to optimise ageing in older Australians: recommendations for a national strategic action plan to reduce inappropriate polypharmacy, University of Sydney, Australia. Open access
2018	Reeve, E, Farrell, B, Thompson, W, Herrmann, N, Sketris, I, Magin, P, Chenoweth, L, Gorman, M, Quirke, L, Bethune, G, Forbes, F & Hilmer, S 2018, Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine, University of Sydney, Australia. Open access

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Alzheimer’s Australia	AUSTRALIA
Alzheimer's Australia	AUSTRALIA
Ang Mo Kio-Thye Hua Kwan Hospital	SINGAPORE
Bloomberg School of Public Health	UNITED STATES
Bond University	AUSTRALIA
Bruyère Research Institute	CANADA
Catholic University of Louvain	BELGIUM
CDPC	AUSTRALIA
Central Adelaide Local Health Network Incorporated	AUSTRALIA
Chemplus Pty Ltd	AUSTRALIA
CHU de Limoges	FRANCE
Cochrane Denmark	DENMARK
Cochrane Sweden	SWEDEN
Concordia University	CANADA
Connolly Hospital Blanchardstown	IRELAND
Curtin University	AUSTRALIA
Dalhousie University	CANADA
Dalhousie University, Faculty of Medicine	CANADA
Dementia Australia	AUSTRALIA
Duke University	UNITED STATES
Durham VA Medical Center	UNITED STATES
Flinders University	AUSTRALIA
Ghent University	BELGIUM
Hammond Care	AUSTRALIA
Harvard University	UNITED STATES
Horizon Health Network	CANADA
Istituto di Ricerche Farmacologiche Mario Negri	ITALY
IWK Health Centre	CANADA
John Peter Smith Hospital	UNITED STATES
Johns Hopkins	UNITED STATES
Johns Hopkins Community Physicians	UNITED STATES
Johns Hopkins University	UNITED STATES
Johns Hopkins University Bloomberg	UNITED STATES
Johns Hopkins University School of Medicine	UNITED STATES
Kaiser Permanente	UNITED STATES
Karolinska Institute	SWEDEN
Khoo Teck Puat Hospital	SINGAPORE
Kolling Institute of Medical Research	AUSTRALIA
Laval University	CANADA
Laval University (Canada)	CANADA
Leiden University	NETHERLANDS
Limoges University	FRANCE
Liverpool Hospital Elizabeth	AUSTRALIA
Louvain Drug Research Institute	BELGIUM
Mario Negri Institute for Pharmacological Research	ITALY
McGill University	CANADA
McMaster University	CANADA
Monash Institute of Pharmaceutical Sciences	AUSTRALIA
Monash University	AUSTRALIA
Monash University Malaysia	MALAYSIA
Murdoch Childrens Research Institute	AUSTRALIA
National Healthcare Group Pharmacy	SINGAPORE
National University Hospital	SINGAPORE
Newcastle University, United Kingdom	UNITED KINGDOM
Northern Adelaide Local Health Network	AUSTRALIA
Nova Scotia Health Authority	CANADA
NPS MedicineWise	AUSTRALIA
NSW Health	AUSTRALIA
Ospedale Maggiore Policlinico	ITALY
Prince of Wales Hospital	AUSTRALIA
Princess Alexandra Hospital	AUSTRALIA
Private Individual	UNITED KINGDOM
Queensland University of Technology	AUSTRALIA
Repatriation General Hospital	AUSTRALIA
Research Libraries UK	UNITED KINGDOM
Resthaven Incorporated	AUSTRALIA
Resthaven Limited	AUSTRALIA
Royal Adelaide Hospital	AUSTRALIA
Royal College of Surgeons	IRELAND
Royal College of Surgeons in Ireland	IRELAND
Royal North Shore Hospital	AUSTRALIA
Royal Prince Alfred Hospital	AUSTRALIA
San Francisco VA Health Care System	UNITED STATES
Sensus Cognition	AUSTRALIA
Singapore General Hospital	SINGAPORE
Sydney Pharmacy School	AUSTRALIA
Tan Tock Seng Hospital	MALAYSIA
Trinity College Dublin	IRELAND
University and University Hospital of Zurich	SWITZERLAND
University of Adelaide	AUSTRALIA
University of Auckland	NEW ZEALAND
University of Bari	ITALY
University of Basel	SWITZERLAND
University of Bern	SWITZERLAND
University of Bristol	UNITED KINGDOM
University of British Columbia	CANADA
University of Calgary	CANADA
University of California San Francisco	UNITED STATES
University of California System	UNITED STATES
University of Colorado Anschutz Medical Campus	UNITED STATES
University of Colorado Denver	UNITED STATES
University of Geneva	SWITZERLAND
University of Groningen	NETHERLANDS
University of Huddersfield	UNITED KINGDOM
University of Illinois at Urbana-Champaign	UNITED STATES
University of Ioannina	GREECE
University of Kentucky	UNITED STATES
University of Lausanne	SWITZERLAND
University of Leeds	UNITED KINGDOM
University of Leicester	UNITED KINGDOM
University of Medicine and Pharmacy Cluj-Napoca	ROMANIA
University of Milan	ITALY
University of Montreal	CANADA
University of New South Wales	AUSTRALIA
University of Newcastle	AUSTRALIA
University of North Texas Health Science Center	UNITED STATES
University of Otago	NEW ZEALAND
University of Ottawa	CANADA
University of Quebec	CANADA
University of Queensland	AUSTRALIA
University of South Australia	AUSTRALIA
University of Southampton	UNITED KINGDOM
University of Southern California	UNITED STATES
University of Southern Denmark	DENMARK
University of Sydney	AUSTRALIA
University of Tasmania	AUSTRALIA
University of Technology Sydney	AUSTRALIA
University of Texas Arlington	UNITED STATES
University of Tokyo	JAPAN
University of Toronto	CANADA
University of Washington	UNITED STATES
University of Waterloo	CANADA
University of Western Australia	AUSTRALIA
University of Wisconsin-Madison	UNITED STATES
University System of Maryland	UNITED STATES
US Department of Veterans Affairs	UNITED STATES
Utrecht University	NETHERLANDS
Veterans Affairs Medical Center	UNITED STATES
Victoria University	AUSTRALIA
Western Sydney Local Health District	AUSTRALIA

External engagement & recognition

Engagement/recognition	Year
Dementia Research Development Fellowship National Health and Medical Research Council (NHMRC) Australian Research Council (ARC)	2020
Executive Committee Member and Chair of Public Engagement Subcommittee Australian Deprescribing Network (ADeN)	2020
Invited Speaker Australian Association of Consultant Pharmacy (AACP) 16th Annual Consultant Clinical Pharmacy Seminar	2020
Invited to provide input on: Baseline report on Quality Use of Medicines and Medicines Safety Â¿Ã›Ã’ Discussion paper for public consultation Australian Commission on Safety and Quality in Health Care	2020
Member Australian Association of Gerontology (AAG)	2020
Member Australasian Pharmaceutical Science Association (APSA)	2020
Member Society of Hospital Pharmacists of Australia (SHPA)	2020
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2020
Member of the Investigator Development Core and Expert Consultant United States Deprescribing Research Network (USDeN)	2020
Steering Committee Member Guidelines International Network (G.I.N.) Australia and New Zealand (ANZ)	2020
Best 'Rapid Fire' Oral Presentation Theo Murphy Australian Frontiers of Science Redefining Health Ageing Together (Australian Academy of Science) Conference	2019
Dementia Research Development Fellowship National Health and Medical Research Council (NHMRC) Australian Research Council (ARC)	2019
Executive Committee Member and Chair of Public Engagement Subcommittee Australian Deprescribing Network (ADeN)	2019
Founding Member Australian Deprescribing Network (ADeN)	2019
Invited Speaker, Annual Scientific Meeting American Geriatrics Society (AGS)	2019
Member Australasian Pharmaceutical Science Association (APSA)	2019
Member Royal North Shore Hospital Scientific Staff Council	2019
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2019
Member NHMRC National Institute for Dementia Research	2019
Member Gerontological Society of America	2019
Member Sydney Dementia Network (dementia)	2019
Member Australian Association of Gerontology (AAG)	2019
Member Society of Hospital Pharmacists of Australia	2019
Member of the Investigator Development Core and Expert Consultant United States Deprescribing Research Network (USDeN)	2019
Plenary speaker Houston Medication Safety Symposium	2019
Plenary Speaker, Annual Meeting Australian Deprescribing Network (ADeN)	2019
Early Achievement Award for Women: 2018 Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2018
Expert Consultant on National Report on Polypharmacy: Medication Overload: How the drive to prescribe is harming older Americans Lown Institute	2018
Founding Member Australian Deprescribing Network (ADeN)	2018
Invited Speaker Swiss Society of Internal Medicine Annual Meeting, Switzerland	2018
Invited Speaker Canadian Frailty Network Conference, Canada	2018
Member Sydney Dementia Network (dementia)	2018
Member Australasian Pharmaceutical Science Association (APSA)	2018
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2018
Member Royal North Shore Hospital Scientific Staff Council	2018
Member Society of Hospital Pharmacists of Australia	2018
Member Gerontological Society of America	2018
Member NHMRC National Institute for Dementia Research	2018
Organising Committee Member, Invited Presenter, Panel Member and Workshop Facilitator Evidence-Based Deprescribing Guideline Symposium, Canada	2018
Dementia Research Development Fellowship National Health and Medical Research Council (NHMRC) Australian Research Council (ARC)	2017
Founding Member Australian Deprescribing Network (ADeN)	2017
Invited Speaker Northwood Research Symposium, Canada	2017
Invited Speaker and Panel Member Pharmacy Association of Nova Scotia Annual Conference, Canada	2017
Member NHMRC National Institute for Dementia Research	2017
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2017
Member Gerontological Society of America	2017
Member Australasian Pharmaceutical Science Association (APSA)	2017
Member Society of Hospital Pharmacists of Australia	2017
Member Royal North Shore Hospital Scientific Staff Council	2017
Symposium Chair and Presenter 21st IAGG World Congress of Gerontology and Geriatrics	2017
Best Oral Presentation (rapid fire presentations) Australian National Dementia Forum, Brisbane	2016
Dementia Research Development Fellowship National Health and Medical Research Council (NHMRC) Australian Research Council (ARC)	2016
Emerging Health Researcher Award Finalist: 2016 Bupa Health Foundation	2016
Founding Member Australian Deprescribing Network (ADeN)	2016
Invited Speaker Australasian Pharmaceutical Science Association Annual Conference, Sydney	2016
Member Gerontological Society of America	2016
Member Australasian Pharmaceutical Science Association (APSA)	2016
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2016
Member NHMRC National Institute for Dementia Research	2016
Member Royal North Shore Hospital Scientific Staff Council	2016
Member Society of Hospital Pharmacists of Australia	2016
Founding Member Australian Deprescribing Network (ADeN)	2015
Invited Session Chair Australian Pharmaceutical Sciences Association (APSA), Australian Society of Clinical and Experimental Pharmacology and Toxicology (ASCEPT) Joint Meeting	2015
Invited Speaker Medicines Management, 41st SHPA National Conference, Melbourne	2015
Member Royal North Shore Hospital Scientific Staff Council	2015
Member Society of Hospital Pharmacists of Australia	2015
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2015
Member Gerontological Society of America	2015
Workshop Convenor Australian Deprescribing Network Annual Workshop, Sydney	2015
Early Career Research Award Presentation (Finalist) New Horizons (Kolling Institute, NSW)	2014
Founding Member Australian Deprescribing Network (ADeN)	2014
Invited Speaker Deprescribing Workshop, Australian Deprescribing Network, Brisbane	2014
Member Gerontological Society of America	2014
Member Royal North Shore Hospital Scientific Staff Council	2014
Member Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)	2014
Member Society of Hospital Pharmacists of Australia	2014
Member Society of Hospital Pharmacists of Australia	2013
Invited Speaker Australian Association of Consultant Pharmacists meeting, Pharmacy Congress Australia	2012
Member Society of Hospital Pharmacists of Australia	2012
Member Society of Hospital Pharmacists of Australia	2011
Member Society of Hospital Pharmacists of Australia	2010

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Comparison of different methods to assess adherence to weekly methotrexate and hydroxychloroquine	Current
Developing strategies to promote the use of treat to target strategies with conventional synthetic disease modifying anti-rheumatic drugs in patients with early rheumatoid arthritis	Current
Optimising outcomes for patients with rheumatoid arthritis via the use of parenteral methotrexate	Completed

Dr Emily Reeve

About me

About me

UniSA Clinical & Health Sciences

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Projects

Outputs

Highlights

Chapters

Journal Articles

Reports

External engagement & recognition

Collaborations

Collaborations

External engagement & recognition

Dementia Research Development Fellowship

Executive Committee Member and Chair of Public Engagement Subcommittee

Invited Speaker

Invited to provide input on: Baseline report on Quality Use of Medicines and Medicines Safety Â¿Ã›Ã’ Discussion paper for public consultation

Member

Member

Member

Member

Member of the Investigator Development Core and Expert Consultant

Steering Committee Member

Best 'Rapid Fire' Oral Presentation

Dementia Research Development Fellowship

Executive Committee Member and Chair of Public Engagement Subcommittee

Founding Member

Invited Speaker, Annual Scientific Meeting

Member

Member

Member

Member

Member

Member

Member

Member

Member of the Investigator Development Core and Expert Consultant

Plenary speaker

Plenary Speaker, Annual Meeting

Early Achievement Award for Women: 2018

Expert Consultant on National Report on Polypharmacy: Medication Overload: How the drive to prescribe is harming older Americans

Founding Member

Invited Speaker

Invited Speaker

Member

Member

Member

Member

Member

Member

Member

Organising Committee Member, Invited Presenter, Panel Member and Workshop Facilitator

Dementia Research Development Fellowship

Founding Member

Invited Speaker

Invited Speaker and Panel Member

Member

Member

Member

Member

Member

Member

Symposium Chair and Presenter

Best Oral Presentation (rapid fire presentations)

Dementia Research Development Fellowship

Emerging Health Researcher Award Finalist: 2016

Founding Member

Invited Speaker

Member

Member

Member

Member

Member